Long-Acting HIV PrEP Drug May Be Available In 2022

The first long-acting HIV prevention medication may be available in the United States as early as the first quarter of 2022. This news comes even as Moderna announced last month that it was set to start human trials of its new HIV mRNA vaccines.

On September 23, the US Food and Drug Administration (FDA) granted priority review status for a New Drug Application (NDA) for cabotegravir, with the target approval date of January 24, 2022. 

Cabotegravir is a long-acting injectable for pre-exposure prophylaxis, or PrEP medication for persons who are at risk of HIV infection and who have had a HIV negative result before starting the drug.

During trials it was found that cabotegravir administered as an intramuscular injection every eight weeks worked better than daily PrEP (oral emtricitabine/tenofovir disoproxil fumarate) pills at preventing HIV. At present,  PrEP is taken as a pill daily, on-demand or periodically. 

Significant Impact On The Lives Of Gay Men And Trans Women

Shannon Hader, the Deputy Executive Director of the Joint United Nations Program on HIV/AIDS, described the findings as “breakthrough that will have a significant impact on the lives of gay men and other men who have sex with men and transgender women when they are at higher risk of HIV infection.”

The review period for a drug is usually 10 months, but the priority review means this will be brought down to six months. If approved, it will be the first long-acting HIV prevention drug. 

“The FDA’s Priority Review designation of cabotegravir long-acting for PrEP underscores the importance of this medicine, supported by the results of the HPTN studies, which demonstrated cabotegravir’s superior efficacy over daily oral FTC/TDF tablets,” Dr Kimberly Smith, , Head of Research & Development at ViiV Healthcare, said in a statement. 

Less than 25% of persons in the US who could benefit from PrEP are currently taking it, and ViiV Healthcare said this underscores the need for additional options to prevent HIV.  

“We believe new options like investigational cabotegravir long-acting for PrEP will help play a significant role in our collective efforts to end the HIV epidemic,” added Kimberly Smith. 

Superior To Daily PrEP Pills

According to ViiV Healthcare, the NDA was based on the results from two phase IIb/III studies, which looked at the safety and efficacy of the medication among 4,566 men who have sex with men and transgender women and 3,223 cisgender women. After an initial oral lead-in phase, cabotegravir was administered as an intramuscular injection every eight weeks. 

The independent Data Safety Monitoring Boards stopped the blinded, randomised part of both studies after “cabotegravir was shown to be superior to daily oral emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) tablets in preventing the acquisition of HIV.” 

The most common adverse reactions that was  observed in at least 1% of the participants included, injection site reactions, diarrhoea, headache, pyrexia, fatigue, sleep disorders, nausea, dizziness, flatulence, and abdominal pain

ViiV Healthcare has not disclosed the pricing details of the new drug. 

© Star Observer 2021 | For the latest in lesbian, gay, bisexual, transgender, queer and intersex (LGBTIQ) news in Australia, be sure to visit starobserver.com.au daily. You can also read our latest magazines or Join us on our Facebook page and Twitter feed.

Note: This article have been indexed to our site. We do not claim ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Fiocruz will deliver the first doses of 100% national vaccine in February thumbnail

Fiocruz will deliver the first doses of 100% national vaccine in February

A vacina totalmente nacional que está sendo produzida pela Fiocruz, terá seu primeiro lote pronto em fevereiro. A Agência Nacional de Vigilância Sanitária (Anvisa) aprovou nesta sexta-feira (7) o registro do Insumo Farmacêutico Ativo (IFA) da vacina Covidshield (Astrazeneca) produzido no Brasil. Com isso, o país poderá ter uma vacina 100% nacional. Em nota, a Fiocruz…
Read More
Sasaki and Miyano GN 2-3 thumbnail

Sasaki and Miyano GN 2-3

At some point, all readers of romance fiction have to come to a very important realization: things rarely, if ever, play out in fiction the same way they do in real life. Sometimes that's just understanding that no Prince Charming is going to show up on a white charger at the opportune moment, so you…
Read More
TVアニメ好評放送中『賢者の弟子を名乗る賢者』コミック最新9巻「特製ミニ画集付特装版」が発売! thumbnail

TVアニメ好評放送中『賢者の弟子を名乗る賢者』コミック最新9巻「特製ミニ画集付特装版」が発売!

マイクロマガジン社(東京都中央区)は、ライドコミックス『賢者の弟子を名乗る賢者 THE COMIC 9』に、B6判ミニ画集「dicca*suemitsu mini-artbook」を同梱した『賢者の弟子を名乗る賢者 THE COMIC 9 特製ミニ画集付特装版』を発売いたしました。賢者の弟子を名乗る賢者 THE COMIC 9 特製ミニ画集付特装版漫画:すえみつぢっか 原作:りゅうせんひろつぐ キャラクター原案:藤ちょこ定価:1,980円(本体1,800円+税10%)発売日:2022年1月31日(月)老練の賢者様が美少女に大変身!?「わしかわいい」系美少女転生冒険ファンタジー『賢者の弟子を名乗る賢者』の公式コミカライズ作品、最新9巻!特装版に付属するミニ画集「dicca*suemitsu mini-artbook」は、コミカライズ担当:すえみつぢっか先生が手掛けた単行本1~8巻分のカバーアートのほか、WEB連載誌『コミックライド』(https://www.comicride.jp//magazine/)の歴代担当表紙イラストを色彩鮮やかに美麗印刷収録した、ファン必見の豪華フルカラー冊子(B6判・32頁)となっています。下記の公式通販、または全国の一部書店にて販売中です。(取り扱い状況/在庫状況はご希望の店舗まで直接お問合せ下さい。)【商品ページ】(公式通販)https://micromagazinestore.com/products/detail/471【通常版情報】賢者の弟子を名乗る賢者 THE COMIC 9(通常版)漫画:すえみつぢっか 原作:りゅうせんひろつぐ キャラクター原案:藤ちょこhttps://micromagazine.co.jp/book/?book_no=1295定価:693円(本体630円+税10%)発売日:2022年1月31日(月)天上廃都を道中で出会った冒険者と共に攻略し、ソウルハウルの痕跡を手に入れたミラ。アルカイト王国へ情報を持ち帰る途中、寄り道をしたことで予想外の出会いが――軌道の先で巡りあう「わしかわいい」ファンタジー第9巻!!原作小説:GCノベルズ『賢者の弟子を名乗る賢者』関連の限定商品も続々発売中!賢者の弟子を名乗る賢者 16 特製冊子付特装版著:りゅうせんひろつぐ イラスト:藤ちょこ(公式通販)https://micromagazinestore.com/products/detail/454定価:2,420円(本体2,200円+税10%)人気イラストレーター、藤ちょこ先生による『賢者の弟子を名乗る賢者』単行本未収録イラスト集&著者:りゅうせんひろつぐ先生による特別書き下ろしの番外編『伝説の始まり』を収録した豪華特製冊子が付属!賢者の弟子を名乗る賢者 1 TVアニメ化記念リーフレット付特装版著:りゅうせんひろつぐ イラスト:藤ちょこ(公式通販)https://micromagazinestore.com/products/detail/455(Amazon)https://www.amazon.co.jp/dp/B09NGZCMRC定価:1,100円(本体1,000円+税10%)TVアニメ版キャラクターの資料カット(ミラ・ソロモン・ルミナリア・ケットシー)を特別収録したほか、りゅうせんひろつぐ先生による、作品初期にPR配布された貴重な掌編『変わらないもの』を復刻再収録した記念リーフレット付き!通常版と同価格のお得な入門パックが数量限定で販売中です。原作小説のまとめ読みセットも取り扱い中!GCノベルズ「賢者の弟子を名乗る賢者」1~16巻セット(公式通販)https://micromagazinestore.com/products/detail/456定価:17,600円(本体16,000円+税10%)好評発売中の関連オフィシャルグッズ等『賢者の弟子を名乗る賢者』商品一覧はこちら!(公式通販)https://micromagazinestore.com/products/list?category_id=44『賢者の弟子を名乗る賢者』【ストーリー】VRMMO『アーク・アース オンライン』で、九賢者の一人という渋い召喚士「ダンブルフ」としてロールプレイしていた咲森鑑(さきもりかがみ)は、プレイ中の寝落ちを境にゲームが現実となった世界へと飛ばされてしまう。しかも、老練な渋い賢者の姿ではなく可憐な少女の姿となって……。このままでは築き上げてきた賢者の威厳が失墜してしまう!そう考えた咲森鑑(さきもり・かがみ)ことダンブルフは、賢者の弟子「ミラ」と名乗るのだったが――。GCノベルズ『賢者の弟子を名乗る賢者』著者:りゅうせんひろつぐ/イラスト:藤ちょこhttps://gcnovels.jp/pupil/ライドコミックス『賢者の弟子を名乗る賢者 THE COMIC』漫画:すえみつぢっか/原作:りゅうせんひろつぐ/キャラクター原案:藤ちょこhttps://www.comicride.jp//book/pupil/『賢者の弟子を名乗る賢者』公式スピンオフ!ライドコミックス『賢者の弟子を名乗る賢者外伝~ミラと素敵な召喚精霊たち~』漫画:うおぬまゆう/原作:りゅうせんひろつぐ/キャラクター原案:藤ちょこhttps://www.comicride.jp//book/pupilside/ライドコミックス『賢者の弟子を名乗る賢者~マリアナの遠き日~』漫画:ばにら棒/原作:りゅうせんひろつぐ/キャラクター原案:藤ちょこhttps://www.comicride.jp/book/mariana/【お問い合せ先】release_mg@microgroup.co.jp企業プレスリリース詳細へPRTIMESトップへ
Read More
Norwegian politics, Nett på sak |  The government is similar to Turkish carpet retailers who challenge the patience of electricity customers thumbnail

Norwegian politics, Nett på sak | The government is similar to Turkish carpet retailers who challenge the patience of electricity customers

Dårlig politikk og grådige offentlige kraftprodusenter tapper fortsatt husholdningene for milliardbeløp, og parhestene Jonas Gahr Støre og Trygve Slagsvold Vedum lar seg drive fra skanse til skanse. Nett på sak Dette er kommentarer skrevet av Nettavisens sjefredaktør. På noen få måneder er den rødgrønne begeistringen over å vinne valget, erstattet med fortvilelse over å ha…
Read More
Index Of News